FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311791640> ?p ?o ?g. }

• W4311791640 endingPage "1815" @default.
• W4311791640 startingPage "1815" @default.
• W4311791640 abstract "The emergence, persistence, and spread of antibiotic-resistant microbes is a tremendous public health threat that is considered nowadays a critical One Health issue. In Lebanon, the consumption of raw bovine milk has been recently reported as a result of the financial crisis. The objectives of the current study were (1) to evaluate raw bovine milk samples in a comprehensive manner for the types of antibiotics used and their residues, (2) to determine the presence of mesophilic bacteria, extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA), and (3) to determine the associated human health risk caused by drinking raw milk with antibiotic residues among all age categories. LC-MS-MS was used to carry out the analysis. From 200 milk samples, 30 (15%) were found contaminated with four major antibiotics. The highest average concentration detected was for oxytetracyline 31.51 ± 13.23 μg/kg, followed by 5.5 ± 0.55 μg/kg for gentamicin, 4.56 ± 0.73 μg/kg for colistin, and 4.44 ± 0.89 μg/kg for tylosin. The mean contamination among most samples was below the maximum residue limits (MRLs). Upon comparison with the acceptable daily intake (ADI), the estimated daily intake (EDI) across all age groups was acceptable. The hazard quotient (HQ) was also below 1 across all age groups, signifying the absence of associated health risks for the Lebanese consumers. On the other hand, all milk samples were found exceeding the maximum tolerable value of mesophilic flora. Antibiotic-resistant bacteria (ARB) were detected and represented by ESBL-producing E. coli and MRSA isolates. Thus, the greatest threat of antibiotic use in Lebanon does not fall under antibiotic residues but rather the proliferation of antibiotic resistance in potentially pathogenic bacteria. In this study, the virulence profile of detected bacteria was not investigated; thus their pathogenicity remains unknown. Therefore, to mitigate this health threat in Lebanon, a One Health action plan against ABR is required. It will provide a framework for continued, more extensive action to reduce the emergence and spread of ABR in Lebanon." @default.
• W4311791640 created "2022-12-28" @default.
• W4311791640 creator A5006893037 @default.
• W4311791640 creator A5009908111 @default.
• W4311791640 creator A5017950301 @default.
• W4311791640 creator A5029613779 @default.
• W4311791640 creator A5035189533 @default.
• W4311791640 creator A5038273500 @default.
• W4311791640 creator A5053840596 @default.
• W4311791640 creator A5059422803 @default.
• W4311791640 creator A5087112151 @default.
• W4311791640 date "2022-12-14" @default.
• W4311791640 modified "2023-09-26" @default.
• W4311791640 title "Prevalence and Antibiotic Resistance of Staphylococcus aureus and Escherichia coli Isolated from Bovine Raw Milk in Lebanon: A study on Antibiotic Usage, Antibiotic Residues, and Assessment of Human Health Risk Using the One Health Approach" @default.
• W4311791640 cites W1976780773 @default.
• W4311791640 cites W1996732652 @default.
• W4311791640 cites W2019191984 @default.
• W4311791640 cites W2038185392 @default.
• W4311791640 cites W2042499089 @default.
• W4311791640 cites W2093287732 @default.
• W4311791640 cites W2110053329 @default.
• W4311791640 cites W2156467115 @default.
• W4311791640 cites W2165046389 @default.
• W4311791640 cites W2179560326 @default.
• W4311791640 cites W2297856069 @default.
• W4311791640 cites W2299586077 @default.
• W4311791640 cites W2408401143 @default.
• W4311791640 cites W2517053746 @default.
• W4311791640 cites W2552936918 @default.
• W4311791640 cites W2754571653 @default.
• W4311791640 cites W2794891594 @default.
• W4311791640 cites W2914408441 @default.
• W4311791640 cites W2939151426 @default.
• W4311791640 cites W2962847529 @default.
• W4311791640 cites W2971665246 @default.
• W4311791640 cites W3003742357 @default.
• W4311791640 cites W3004532463 @default.
• W4311791640 cites W3005363101 @default.
• W4311791640 cites W3012932665 @default.
• W4311791640 cites W3013388799 @default.
• W4311791640 cites W3014655349 @default.
• W4311791640 cites W3037708216 @default.
• W4311791640 cites W3039465671 @default.
• W4311791640 cites W3044397677 @default.
• W4311791640 cites W3111098997 @default.
• W4311791640 cites W3118690266 @default.
• W4311791640 cites W3159098632 @default.
• W4311791640 cites W3174837867 @default.
• W4311791640 cites W3191621270 @default.
• W4311791640 cites W3216569429 @default.
• W4311791640 cites W4200541999 @default.
• W4311791640 cites W4205233632 @default.
• W4311791640 cites W4206677002 @default.
• W4311791640 cites W4220744632 @default.
• W4311791640 cites W4224240567 @default.
• W4311791640 cites W4247726677 @default.
• W4311791640 cites W4248599173 @default.
• W4311791640 cites W4281287179 @default.
• W4311791640 cites W4289170422 @default.
• W4311791640 cites W4293207111 @default.
• W4311791640 doi "https://doi.org/10.3390/antibiotics11121815" @default.
• W4311791640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36551472" @default.
• W4311791640 hasPublicationYear "2022" @default.
• W4311791640 type Work @default.
• W4311791640 citedByCount "0" @default.
• W4311791640 crossrefType "journal-article" @default.
• W4311791640 hasAuthorship W4311791640A5006893037 @default.
• W4311791640 hasAuthorship W4311791640A5009908111 @default.
• W4311791640 hasAuthorship W4311791640A5017950301 @default.
• W4311791640 hasAuthorship W4311791640A5029613779 @default.
• W4311791640 hasAuthorship W4311791640A5035189533 @default.
• W4311791640 hasAuthorship W4311791640A5038273500 @default.
• W4311791640 hasAuthorship W4311791640A5053840596 @default.
• W4311791640 hasAuthorship W4311791640A5059422803 @default.
• W4311791640 hasAuthorship W4311791640A5087112151 @default.
• W4311791640 hasBestOaLocation W43117916401 @default.
• W4311791640 hasConcept C2775832221 @default.
• W4311791640 hasConcept C2775992197 @default.
• W4311791640 hasConcept C2779489039 @default.
• W4311791640 hasConcept C31903555 @default.
• W4311791640 hasConcept C42972112 @default.
• W4311791640 hasConcept C501593827 @default.
• W4311791640 hasConcept C523546767 @default.
• W4311791640 hasConcept C54355233 @default.
• W4311791640 hasConcept C71924100 @default.
• W4311791640 hasConcept C86803240 @default.
• W4311791640 hasConcept C89423630 @default.
• W4311791640 hasConcept C94665300 @default.
• W4311791640 hasConceptScore W4311791640C2775832221 @default.
• W4311791640 hasConceptScore W4311791640C2775992197 @default.
• W4311791640 hasConceptScore W4311791640C2779489039 @default.
• W4311791640 hasConceptScore W4311791640C31903555 @default.
• W4311791640 hasConceptScore W4311791640C42972112 @default.
• W4311791640 hasConceptScore W4311791640C501593827 @default.
• W4311791640 hasConceptScore W4311791640C523546767 @default.
• W4311791640 hasConceptScore W4311791640C54355233 @default.
• W4311791640 hasConceptScore W4311791640C71924100 @default.
• W4311791640 hasConceptScore W4311791640C86803240 @default.

• next